Affle 3i Limited has announced that its Board of Directors will convene on May 9, 2026, to evaluate critical strategic items. The meeting agenda includes the review and approval of the company’s audited standalone and consolidated financial results for the fourth quarter and the full financial year ending March 31, 2026. Furthermore, the board will discuss a proposal to raise up to $120 million through a preferential issue of equity shares or warrants.
Upcoming Board Meeting Details
The Board of Directors of Affle 3i Limited is scheduled to meet on Saturday, May 9, 2026. The primary objective of this meeting is to finalize and approve the financial performance of the company for the quarter and year ended March 31, 2026. Investors are looking forward to these results as they provide the final pulse on the company’s growth trajectory for the 2025-26 fiscal year.
Proposed Capital Raise
A significant highlight of the upcoming board discussion is a proposal for a major capital infusion. The company plans to raise up to $120 million via a preferential issue of securities. This initiative will involve the potential issuance of either equity shares or warrants. The board will also review the necessary ancillary actions, including the preparation of the notice required to seek shareholder approval for this strategic financial move.
Trading Window Update
In accordance with the company’s internal code of conduct, the trading window for company securities has been closed. This restriction commenced on April 1, 2026, and will remain in effect until 48 hours after the official declaration of the financial results for the quarter and year ended March 31, 2026. This measure is in place to ensure compliance with insider trading guidelines during the finalization of the annual financial report.
Source: BSE
